HF
INBX

HRT Financial’s Inhibrx, Inc. Common Stock INBX Stock Holding History

HRT Financial’s Portfolio INBX Stock Details INBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-31,084
Closed -$570K – 3394
2023
Q3 		$570K Buy
+31,084
New +$650K 0.01% 1339
2022
Q3 		– Sell
-29,900
Closed -$339K – 3915
2022
Q2 		$339K Buy
+29,900
New +$440K ﹤0.01% 1940

Other funds holding INBX

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

HRT Financial's INBX Position: Q4 2023 in Review

HRT Financial sold out of Inhibrx, Inc. Common Stock (INBX) in Q4 2023, closing a stake of 31,084 shares — an estimated $570K sold.

HRT Financial first reported a position in INBX in Q2 2022 and held it in 2 quarters. The position peaked at $570K in Q3 2023. 127 funds tracked by Wall St. Rank hold INBX as of Q4 2023.

  • HRT Financial reported no remaining Inhibrx, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • HRT Financial sold 31,084 Inhibrx, Inc. Common Stock shares in Q4 2023, an estimated $570K.
  • HRT Financial first reported a position in Inhibrx, Inc. Common Stock in Q2 2022 and held it in 2 quarters.
  • HRT Financial's Inhibrx, Inc. Common Stock position peaked at $570K in Q3 2023.
  • 127 funds tracked by Wall St. Rank held Inhibrx, Inc. Common Stock as of Q4 2023.

Based on HRT Financial's 13F filing for Q4 2023, filed 9 Feb 2024.